-
Michel Sadelain (born 1960) is an
genetic engineer and cell
therapist at
Memorial Sloan Kettering Cancer Center, New York, New York,
where he
holds the...
- (8): 494–502. doi:10.1016/j.it.2015.06.004. PMC 4746114. PMID 26169254.
Sadelain M,
Brentjens R, Rivière I (April 2013). "The
basic principles of chimeric...
- been
shown to
induce islet beta cell regeneration.
Immunologic adjuvant Sadelain, MW; Qin, HY; Lauzon, J; Singh, B (1990), "Prevention of type I diabetes...
- 365 (8): 725–33. doi:10.1056/nejmoa1103849. PMC 3387277. PMID 21830940.
Sadelain M (December 2017). "CD19 CAR T Cells". Cell. 171 (7): 1471. doi:10.1016/j...
- (7216): 1109–13. doi:10.1038/nature07336. PMC 2574766. PMID 18806780.
Sadelain MW, Qin HY,
Lauzon J,
Singh B (1990). "Prevention of type I
diabetes in...
-
Silverman 2024
Pascal Mayer,
Shankar Balasubramanian,
David Klenerman,
Michel Sadelain,
Zelig Eshhar Canada Gairdner Global Health Award Canada Gairdner Wightman...
- 145 (2): dev148874. doi:10.1242/dev.148874. PMID 29374062.
Themeli M,
Sadelain M (April 2016). "Combinatorial
Antigen Targeting:
Ideal T-Cell Sensing...
- T-cells is the key to
success of the treatment.
Oncogenomics Miller JF,
Sadelain M (April 2015). "The
journey from
discoveries in
fundamental immunology...
-
Rosenberg (born 1940) United
States National Cancer Institute Michel Sadelain (born 1960) United
States Memorial Sloan Kettering Cancer Center Rob Knight...
- cells."
Perelman School of Medicine,
University of
Pennsylvania Michel Sadelain France
Memorial Sloan Kettering Cancer Center Sabine Hadida Spain United...
